AI
JAZZ icon

AdvisorShares Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

AdvisorShares Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,400
Closed -$748K – 303
2025
Q4 		$748K Sell
4,400
-740
-14% -$113K 0.12% 96
2025
Q3 		$677K Sell
5,140
-5,200
-50% -$624K 0.11% 99
2025
Q2 		$1.1M Sell
10,340
-1,420
-12% -$154K 0.2% 65
2025
Q1 		$1.47M Buy
11,760
+1,300
+12% +$170K 0.29% 45
2024
Q4 		$1.29M Buy
10,460
+5,560
+113% +$655K 0.25% 42
2024
Q3 		$546K Sell
4,900
-5,000
-51% -$548K 0.1% 81
2024
Q2 		$1.05M Hold
9,900
– – 0.18% 51
2024
Q1 		$1.19M Buy
9,900
+2,000
+25% +$245K 0.2% 47
2023
Q4 		$972K Sell
7,900
-1,102
-12% -$138K 0.23% 47
2023
Q3 		$1.17M Sell
9,002
-3,420
-28% -$456K 0.31% 38
2023
Q2 		$1.54M Sell
12,422
-1,300
-9% -$175K 0.44% 33
2023
Q1 		$2.01M Sell
13,722
-45,515
-77% -$6.73M 0.63% 21
2022
Q4 		$9.44M Buy
59,237
+30,000
+103% +$4.4M 2.66% 5
2022
Q3 		$3.9M Buy
29,237
+9,128
+45% +$1.39M 1.05% 9
2022
Q2 		$3.14M Buy
20,109
+3,378
+20% +$520K 0.87% 11
2022
Q1 		$2.6M Buy
16,731
+1,125
+7% +$163K 0.43% 16
2021
Q4 		$1.99M Sell
15,606
-5,760
-27% -$757K 0.24% 43
2021
Q3 		$2.78M Sell
21,366
-7,441
-26% -$1.12M 0.44% 16
2021
Q2 		$5.12M Buy
+28,807
New +$4.99M 0.7% 16

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AdvisorShares Investments's JAZZ Position: Q1 2026 in Review

AdvisorShares Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 4,400 shares — an estimated $748K sold.

AdvisorShares Investments first reported a position in JAZZ in Q2 2021 and held it in 19 quarters. The position peaked at $9.44M in Q4 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • AdvisorShares Investments reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AdvisorShares Investments sold 4,400 Jazz Pharmaceuticals shares in Q1 2026, an estimated $748K.
  • AdvisorShares Investments first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 19 quarters.
  • AdvisorShares Investments's Jazz Pharmaceuticals position peaked at $9.44M in Q4 2022.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on AdvisorShares Investments's 13F filing for Q1 2026, filed 28 Apr 2026.